Mitochondria-Targeting Type-I Photodynamic Therapy Based on Phenothiazine for Realizing Enhanced Immunogenic Cancer Cell Death via Mitochondrial Oxidative Stress
Zeyu Duan,1,* Lie Li,1,* Qiyu Zhan,1 Jian Chen,1 Qiyan Li,1 Ruiyuan Liu,1,* Yinuo Tu2,* 1Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, People’s Republic of China; 2Guangzhou Institute of Cancer Research...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/mitochondria-targeting-type-i-photodynamic-therapy-based-on-phenothiaz-peer-reviewed-fulltext-article-IJN |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Zeyu Duan,1,* Lie Li,1,* Qiyu Zhan,1 Jian Chen,1 Qiyan Li,1 Ruiyuan Liu,1,* Yinuo Tu2,* 1Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, People’s Republic of China; 2Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 510095, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ruiyuan Liu; Yinuo Tu, Email ruiyliu@smu.edu.cn; tuyinuo@gzhmu.edu.cnPurpose: Photo-immunotherapy faces challenges from poor immunogenicity and low response rate due to hypoxic microenvironment. This study presents Rh-PTZ, a small organic molecule with a D-π-A structure, that simultaneously amplifies mitochondria-targeted type-I PDT-dependent immune stimulation for the treatment of hypoxic cancer.Methods: The hydrophobic Rh-PTZ was encapsulated into F127 to prepare Rh-PTZ nanoparticles (Rh-PTZ NPs). The type-I ROS generation ability, mitochondrial targeting capacity, and ICD triggering effect mediated by Rh-PTZ NPs under LED light irradiation were investigated. Based on a 4T1 subcutaneous tumor model, the in vivo biological safety assessment, in vivo NIR fluorescent imaging, and the efficacy of PDT were assessed.Results: Rh-PTZ could efficiently accumulate in the mitochondrial site and induce O2•− and •OH burst in situ under LED light irradiation, thereby causing severe mitochondrial dysfunction. Rh-PTZ can amplify mitochondrial stress-caused immunogenic cell death (ICD) to stimulate the immune response, promote the maturation of sufficient dendritic cells (DCs), enhance the infiltration of immune cells, and alleviate the tumor immunosuppressive microenvironment.Conclusion: The mitochondria-targeting type-I PDT holds promise to enhance photo-immunotherapy for hypoxia tumor treatment and overcoming the limitations of traditional immunotherapy.Keywords: Photo-immunotherapy, immunogenic cell death, Type-I photosensitizers, mitochondrial targeting |
|---|---|
| ISSN: | 1178-2013 |